Skip to content
akaturk Academic measurement
2025 SJR Q2 JCR Q1 · 4,1 245 matched articles SCIE

Journal detail

Clinical Lymphoma, Myeloma and Leukemia

Publisher
Elsevier Inc.
Country
United States · Northern America
Type
journal
ISSN
  • 21522650
  • 21522669
Scopus 0,615 SJR
Scopus Q2 SJR Q
WoS Q1 JCR Q
WoS 4,1 JIF
Scopus 71 H-Index

Integrated evaluation

Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.

WoS / JCR data covers 1997 onward.

Scopus

Scopus · Scimago

  • SJR 0,615
  • Quartile Q2
  • H-Index 71
  • Cites/doc 2,7
  • Docs (3y) 1.077
  • Cites (3y) 1.413

Clarivate

Web of Science · JCR · 2025

  • JCR Q Q1
  • JIF 4,1
  • 5Y JIF 2,8
  • JCI 0,56

WoS indexes

  • SCIE

Subject classification

Yearly quartile comparison

Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.

WoS / JCR data covers 1997 onward.

Note: JCR Q, JIF, 5Y JIF, JCI, and JCI Q are blank before 1997 — WoS/JCR data on this site starts in 1997.
Year SJR Q JCR Q (1997+) SJR JIF (1997+) 5Y JIF (1997+) JCI (1997+) JCI Q (1997+) H-Index
2025 Q2 Q1 0,615 4,1 2,8 0,56 Q2 71
2024 Q3 Q2 0,513 2,7 2,4 0,49 Q3 68
2023 Q3 Q2 0,548 2,7 2,4 0,48 Q3 68
2022 Q2 Q3 0,758 2,7 2,5 0,44 Q3 68
2021 Q2 Q3 0,778 2,8 2,6 0,45 Q3 68
2020 Q2 Q3 0,94 3,2 2,9 0,5 Q3 68
2019 Q2 Q3 0,819 2,3 2,2 0,48 Q3 68
2018 — Q3 — 2,3 2,2 0,5 Q3 —
2017 Q2 Q3 0,895 2,3 2,2 0,49 Q3 68
2016 Q2 Q3 0,772 2,5 2,2 — — 68
2015 Q2 Q3 0,879 2,3 2,1 — — 68
2014 Q2 Q3 0,82 2 1,7 — — 68
2013 Q2 Q3 0,797 1,9 1,7 — — 68
2012 Q2 Q3 0,839 1,7 1,5 — — 68
2011 Q2 Q3 0,89 1,9 1,6 — — 68
2010 Q2 Q3 0,671 2 1,8 — — 68

JCR category quartile history

JCR / JCI quartile by year and category. 1997 and later.

WoS / JCR data covers 1997 onward.

Note: This table shows Clarivate category quartile records from 1997 onward.
Year Category Edition JCR Q (1997+) JCI Q (1997+) Rank
2025 HEMATOLOGY SCIE Q1 Q2 25/103
2025 ONCOLOGY SCIE Q2 Q3 111/333
2024 HEMATOLOGY SCIE Q2 Q3 37/99
2024 ONCOLOGY SCIE Q3 Q3 171/328
2023 HEMATOLOGY SCIE Q2 Q3 35/97
2023 ONCOLOGY SCIE Q3 Q3 163/322
2022 HEMATOLOGY SCIE Q3 Q3 52/79
2022 ONCOLOGY SCIE Q3 Q3 173/241
2021 HEMATOLOGY SCIE Q3 Q3 56/78
2021 ONCOLOGY SCIE Q4 Q3 192/245
2020 HEMATOLOGY SCIE Q3 Q3 41/76
2020 ONCOLOGY SCIE Q3 Q3 173/242
2019 HEMATOLOGY SCIE Q3 Q3 47/76
2019 ONCOLOGY SCIE Q3 Q3 183/244
2018 HEMATOLOGY SCIE Q3 Q3 49/73
2018 ONCOLOGY SCIE Q3 Q3 167/230
2017 HEMATOLOGY SCIE Q3 Q3 42/71
2017 ONCOLOGY SCIE Q3 Q3 164/223
2016 HEMATOLOGY SCIE Q3 — 38/70
2016 ONCOLOGY SCIE Q3 — 137/217
2015 HEMATOLOGY SCIE Q3 — 45/70
2015 ONCOLOGY SCIE Q3 — 136/213
2014 HEMATOLOGY SCIE Q3 — 48/68
2014 ONCOLOGY SCIE Q3 — 150/211
2013 HEMATOLOGY SCIE Q3 — 47/68
2013 ONCOLOGY SCIE Q3 — 142/203
2012 HEMATOLOGY SCIE Q3 — 48/67
2012 ONCOLOGY SCIE Q4 — 148/197
2011 HEMATOLOGY SCIE Q3 — 47/68
2011 ONCOLOGY SCIE Q3 — 129/196
2010 HEMATOLOGY SCIE Q3 — 46/66
2010 ONCOLOGY SCIE Q3 — 118/185